Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changcheng Luo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
World Journal of Urology|January 23, 2020
Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat modelMengyang Zhang, Changcheng Luo, Kai Cui, et al.
Human Mutation|May 6, 2026
A Single-Cell Multiomics Pipeline Maps YBX1 as a Functional Biomarker for Immune Evasion and Therapeutic Resistance in Prostate AdenocarcinomaChangcheng Luo, Dongxu Lin, Jingmin Yang, et al.
Oxidative Medicine and Cellular Longevity|May 19, 2021
Human Tissue Kallikrein 1 Is Downregulated in Elderly Human Prostates and Possesses Potential In Vitro Antioxidative and Antifibrotic Effects in Rodent ProstatesMengyang Zhang, Changcheng Luo, Dongxu Lin, et al.
Oxidative Medicine and Cellular Longevity|February 14, 2022
Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent WayMengyang Zhang, Dongxu Lin, Changcheng Luo, et al.
Journal of Immunology Research|June 27, 2022
Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic ProstatitisDongxu Lin, Mengyang Zhang, Changcheng Luo, et al.
Biochemical and Biophysical Research Communications|January 7, 2023
saKLK1-374 is more difficult to induce KLK1 expression in normal prostate cell lines than that in prostate cancer cell lines: Rethinking the universality of RNA activationMengyang Zhang, Dongxu Lin, Changcheng Luo, et al.
Lasers in Medical Science|May 17, 2025
1470 nm diode laser enucleation versus bipolar transurethral resection of the prostate for the surgical management of benign prostatic hyperplasia: a randomized comparisonDongxu Lin, Changcheng Luo, Kai Cui, et al.
Scientific Reports|October 20, 2023
High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expressionPengyu Wei, Dongxu Lin, Changcheng Luo, et al.
European Journal of Pharmacology|December 3, 2022
Cryptotanshinone modulates proliferation, apoptosis, and fibrosis through inhibiting AR and EGFR/STAT3 axis to ameliorate benign prostatic hyperplasia progressionPengyu Wei, Dongxu Lin, Mengyang Zhang, et al.
Bladder (San Francisco, Calif.)|November 29, 2023
The Expression and Function of Piezo Channels in BladderZhipeng Li, Dongxu Lin, Changcheng Luo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
World Journal of Urology|January 23, 2020
Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat modelMengyang Zhang, Changcheng Luo, Kai Cui, et al.
Human Mutation|May 6, 2026
A Single-Cell Multiomics Pipeline Maps YBX1 as a Functional Biomarker for Immune Evasion and Therapeutic Resistance in Prostate AdenocarcinomaChangcheng Luo, Dongxu Lin, Jingmin Yang, et al.
Oxidative Medicine and Cellular Longevity|May 19, 2021
Human Tissue Kallikrein 1 Is Downregulated in Elderly Human Prostates and Possesses Potential In Vitro Antioxidative and Antifibrotic Effects in Rodent ProstatesMengyang Zhang, Changcheng Luo, Dongxu Lin, et al.
Oxidative Medicine and Cellular Longevity|February 14, 2022
Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent WayMengyang Zhang, Dongxu Lin, Changcheng Luo, et al.
Journal of Immunology Research|June 27, 2022
Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic ProstatitisDongxu Lin, Mengyang Zhang, Changcheng Luo, et al.
Biochemical and Biophysical Research Communications|January 7, 2023
saKLK1-374 is more difficult to induce KLK1 expression in normal prostate cell lines than that in prostate cancer cell lines: Rethinking the universality of RNA activationMengyang Zhang, Dongxu Lin, Changcheng Luo, et al.
Lasers in Medical Science|May 17, 2025
1470 nm diode laser enucleation versus bipolar transurethral resection of the prostate for the surgical management of benign prostatic hyperplasia: a randomized comparisonDongxu Lin, Changcheng Luo, Kai Cui, et al.
Scientific Reports|October 20, 2023
High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expressionPengyu Wei, Dongxu Lin, Changcheng Luo, et al.
European Journal of Pharmacology|December 3, 2022
Cryptotanshinone modulates proliferation, apoptosis, and fibrosis through inhibiting AR and EGFR/STAT3 axis to ameliorate benign prostatic hyperplasia progressionPengyu Wei, Dongxu Lin, Mengyang Zhang, et al.
Bladder (San Francisco, Calif.)|November 29, 2023
The Expression and Function of Piezo Channels in BladderZhipeng Li, Dongxu Lin, Changcheng Luo, et al.
Pageof 2